Inotuzumab Ozogamicin (IO) and Donor Lymphocyte Infusion (DLI) are a Safe and Promising Combination in Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

被引：0
|
作者：
Papayannidis, Cristina [1 ]
Sartor, Chiara [2 ]
Dominietto, Alida [3 ]
Zappone, Elisabetta [4 ]
Marconi, Giovanni [2 ]
Abbenante, Maria Chiara [5 ]
Parisi, Sarah [2 ]
Robustelli, Valentina [2 ]
Terragna, Carolina [1 ]
Nanni, Jacopo [2 ]
Soverini, Simona [2 ]
Cristiano, Gianluca [2 ]
Arpinati, Mario [1 ]
Paolini, Stefania [1 ]
Martinelli, Giovanni [6 ]
Curti, Antonio [1 ]
Cavo, Michele [2 ]
Bonifazi, Francesca [1 ]
机构：
[1] Azienda Osped Univ St Orsola Malpighi, Ist Ematol, Bologna, Italy
[2] Univ Bologna Osped St Orsola Malpighi, Ist Ematol Seragnoli, Bologna, Italy
[3] IRCCS Osped Policlin San Martino, Genoa, Italy
[4] AOUS Siena, Policlin Scotte, UOC Ematol, Siena, Italy
[5] UOC Ematol, Casa Cura Sollievo Sofferenza, San Giovanni Rotondo, Italy
[6] IRST Ist Sci Romagnolo Cura & Studio Tumori, Meldola, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
acute lymphoblastic leukemia; ALL; inotuzumab ozogamicin; donor lymphocyte infusion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ALL-073
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [41] Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
    Harada, Kaito
    Mizuno, Shohei
    Yano, Shingo
    Takami, Akiyoshi
    Ishii, Hiroto
    Ikegame, Kazuhiro
    Najima, Yuho
    Kako, Shinichi
    Ashida, Takashi
    Shiratori, Souichi
    Ota, Shuichi
    Onizuka, Makoto
    Fukushima, Kentaro
    Fukuda, Takahiro
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yanada, Masamitsu
    ANNALS OF HEMATOLOGY, 2022, 101 (03) : 643 - 653
  • [42] A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT).
    De Lima, Marcos J. G.
    Kebriaei, Partow
    Lanza, Francesco
    Cho, Christina
    Giralt, Sergio
    Popradi, Gizelle
    Hemmer, Michael T.
    Zhang, Xin
    Shah, Richa
    Welch, Verna L.
    Vandendries, Erik
    Stelljes, Matthias
    Marks, David I.
    Saber, Wael
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia
    Prockop, Susan
    Wachter, Franziska
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2023, 36 (03)
  • [44] Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Micheva, Ilina
    Gerov, Vladimir
    Dimitrova, Stela
    Efraim, Merlin
    CASE REPORTS IN HEMATOLOGY, 2021, 2021
  • [45] Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study
    Lee, Seung-Hwan
    Yoon, Jae-Ho
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Lee, Seok
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (01) : 135 - 139
  • [46] Donor Lymphocyte Infusion for the Treatment of Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
    Takami, Akiyoshi
    Yano, Shingo
    Yokoyama, Hiroki
    Kuwatsuka, Yachiyo
    Yamaguchi, Takuhiro
    Kanda, Yoshinobu
    Morishima, Yasuo
    Fukuda, Takahiro
    Miyazaki, Yasushi
    Nakamae, Hirohisa
    Tanaka, Junji
    Atsuta, Yoshiko
    Kanamori, Heiwa
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1785 - 1790
  • [47] MISMATCHED DONOR LYMPHOCYTE INFUSIONS FOR RELAPSED ACUTE LEUKEMIA FOLLOWING HLA IDENTICAL ALLOGENEIC STEM CELL TRANSPLANT
    Melver, Z. A.
    Battiwalla, M.
    Barrett, A. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S215 - S215
  • [48] Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant
    Hui-Ching Wang
    Yi-Chang Liu
    Yu-Fen Tsai
    Cheng-Han Wu
    Shih-Feng Cho
    Hui-Hua Hsiao
    Ching-Ping Lee
    Sheng-Fung Lin
    Ta-Chih Liu
    Annals of Hematology, 2015, 94 : 887 - 888
  • [49] Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy
    Michallet, AS
    Nicolini, F
    Michallet, M
    BULLETIN DU CANCER, 2003, 90 (8-9) : 758 - 762
  • [50] Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant
    Wang, Hui-Ching
    Liu, Yi-Chang
    Tsai, Yu-Fen
    Wu, Cheng-Han
    Cho, Shih-Feng
    Hsiao, Hui-Hua
    Lee, Ching-Ping
    Lin, Sheng-Fung
    Liu, Ta-Chih
    ANNALS OF HEMATOLOGY, 2015, 94 (05) : 887 - 888
12345